21 June 2024 : Original article
Long-Term Graft and Patient Survival After Re-Transplantation
Dana Bielopolski
12ACDEF*, Aviad Gravetz 34DE, Timna Agur 54E, Renana Yemini 2E, Benaya Rozen Zvi 54ACDE, Eviatar Nesher 64DE
DOI: 10.12659/AOT.943903
Ann Transplant 2024; 29:e943903
Table 1 Demographic and clinical characteristics of patients.
| Characteristics | Group A (n=1820) | Group B (n=285) | Group C (n=74) | Total (n=2152) | p-value |
|---|---|---|---|---|---|
| Recipient age (years, SD) | 51±15 | 43±14 | 44±12 | 50±17 | 0.000* |
| Gender (n women, %) | 656 (32%) | 107 (36%) | 31 (37%) | 706 (32%) | 0.186 |
| IHD (n, %) | 368 (20%) | 34 (13%) | 14 (19%) | 416 (19%) | 0.027 |
| DM (n, %) | 501 (27%) | 42 (16%) | 5 (7%) | 548 (25%) | 0.001 |
| PRA (mean, SD) | 184 (10%) | 113 (43%) | 54 (70%) | 351 (16%) | 0.001 |
| Time on dialysis (months, SD) | 34±36 | 57±60 | 65±67 | 38±42 | 0.000* |
| Induction (rATG) (n, %) | 508 (30%) | 199 (80%) | 71 (95%) | 621 (38%) | 0.000** |
| DGF | 174 (9.6%) | 34 (13.2%) | 11 (14.9%) | 219 (10%) | 0.079 |
| Hospitalization (days, SD) | 12.7±13 | 15.7±25 | 14±9 | 13±15 | 0.000 |
| Donor age (years, SD) | 46±14 | 41±13 | 42±12 | 45±14 | 0.000 |
| Donor (n living, %) | 1073 (59%) | 157 (61%) | 47 (63%) | 1277 (59%) | 0.000 |
| * Difference driving the statistical significance was between groups 1 and 2 in the case of time on dialysis, time from transplantation to death, and between groups 1 and 2, and 1 and 3 in case of age; ** information on induction type was missing for 304 cases in total, from all 3 groups. PRA – panel-reactive antibodies; rATG – rabbit anti-thymocyte globulin; DGF – delayed graft function. Hospitalization relates to length of admission after transplantation. | |||||